Davidson Kempner Capital Management LP Seagen Inc. Transaction History

Davidson Kempner Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.0 - $228.9 $0 - $563 Million	-2,459,732 Closed	0 $0
Q3 2023 Feb 14, 2024	BUY	$191.51 - $216.16 $149 Million - $168 Million	777,503 Added 46.22%	2,459,732 $522 Million
Q2 2023 Feb 14, 2024	BUY	$187.64 - $206.25 $305 Million - $335 Million	1,623,764 Added 2777.33%	1,682,229 $324 Million
Q1 2023 Feb 14, 2024	BUY	$127.59 - $203.08 $7.46 Million - $11.9 Million	58,465 New	58,465 $11.8 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $3.12 Million - $4.15 Million	23,037 Added 228.11%	33,136 $4.53 Million
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $1.1 Million - $1.81 Million	10,099 New	10,099 $1.79 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Davidson Kempner Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Davidson Kempner Capital Management LP with notifications on news.